Vaxcyte

Vaxcyte

HQ
San Carlos, CA
170 Total Employees

Jobs at Similar Companies

Similar Companies Hiring

Machine Learning • Design • Biotech • Artificial Intelligence
Boston, MA
95 Employees
Virtual Reality • Software • Kids + Family • Healthtech • Gaming • Consumer Web • Biotech
4 Offices
387 Employees
Software • Pharmaceutical • Machine Learning • Biotech • Big Data • Artificial Intelligence • Analytics
11 Offices
63000 Employees

Vaxcyte is a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. The Company is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Vaxcyte’s lead candidate, VAX-24, is a 24-valent, broad-spectrum pneumococcal conjugate vaccine being developed for the prevention of invasive pneumococcal disease. Vaxcyte is re-engineering the way highly complex immunizations are made through modern synthetic techniques, including advanced chemistry and the XpressCFᵀᴹ cell-free protein synthesis platform, exclusively licensed from Sutro Biopharma, Inc. Unlike conventional cell-based approaches, the Company’s system for producing difficult-to-make proteins and antigens is intended to accelerate its ability to efficiently create and deliver high-fidelity vaccines with enhanced immunological benefits. Vaxcyte’s pipeline also includes VAX-XP, a PCV with an expanded breadth of coverage of greater than 30 strains; VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep infections; and VAX-PG, a therapeutic vaccine candidate designed to slow or stop the progression of periodontal disease. Vaxcyte is driven to eradicate or treat invasive bacterial infections, which have serious and costly health consequences when left unchecked.


Vaxcyte Offices

OnSite Workspace

Employees work from physical offices.

Typical time on-site: None
HQSan Carlos, CA